Antara Badhan

Dr. Antara Badhan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2021 in Journal of Solar Energy Engineering
Verified
Journal Article
Open access
PDF file
SASamia Afrin
Samia Afrin
NHNazmul Hossain
Nazmul Hossain
ZMZhiwen Ma
Zhiwen Ma
VKV M Krushnarao Kotteda
V M Krushnarao Kotteda
ABAntara Badhan
Antara Badhan
VKVinod Kumar
Vinod Kumar
Concentrated solar power (CSP) is a promising technology in transitioning to renewable energy because of its abundance in nature and thermal energy storage (TES) capability. Among the four types of available CSP technology, including parabolic trough, linear Fresnel, power tower, and parabolic dishes, a power tower using a central receiver has more potential to generate high-temperature heat in a scale supporting power cycles efficiency and achieve low levelized cost of energy (LCOE). Other than the conventional type of receiver design, the high-absorptive receiver concept developed and presented in this paper is novel in its design approach. The novel receiver design originated from National Renewable Energy Laboratory (NREL) consists of an array of solar flux absorb tubes. The solar absorb tubes require uniform flux distribution and in-depth flux penetration through the three different reflective sections of tubes in a hexagonal shape. To evaluate this unique receiver design and thermal performance, the flux distribution, flux uniformity, and intensity were numerically simulated using ansys fluent and SolTrace modeling program. On-sun testing has been done at NREL high flux solar testing facility, based on the computational analysis.

16 July 2021
Verified
Preprint
Open access
VKV M Krushnarao Kotteda
V M Krushnarao Kotteda
ABAntara Badhan
Antara Badhan
VKVinod Kumar
Vinod Kumar
Dry powder inhalers (DPIs) are a combination of active pharmaceutical ingredient (API) and significantly larger carrier particles, which are widely used for pulmonary drug delivery. The micro-sized drug particles - which have a vigorous intensity to aggregate and poor aerosolization performance and mixed with significantly large carrier particles that are unable to penetrate the

28 May 2021 in ASCE-ASME Journal of Risk and Uncertainty in Engineering Systems, Part B. Mechanical Engineering
Verified
Journal Article
Closed access
PDF file
ABAntara Badhan
Antara Badhan
VKV M Krushnarao Kotteda
V M Krushnarao Kotteda
SASamia Afrin
Samia Afrin
VKVinod Kumar
Vinod Kumar
Dry powder inhalers (DPI), used as a means for pulmonary drug delivery, typically contain a combination of active pharmaceutical ingredients (API) and significantly larger carrier particles. The microsized drug particles—which have a strong propensity to aggregate and poor aerosolization performance—are mixed with significantly large carrier particles that cannot penetrate the mouth-throat region to deagglomerate and entrain the smaller API particles in the inhaled airflow. Therefore, a DPI's performance depends on the carrier-API combination particles' entrainment and the time and thoroughness of the individual API particles' deagglomeration from the carrier particles. Since DPI particle transport is significantly affected by particle-particle interactions, particle sizes and shapes present significant challenges to computational fluid dynamics (CFD) modelers to model regional lung deposition from a DPI. We employed the Particle-In-Cell method for studying the transport/deposition and the agglomeration and deagglomeration for DPI carrier and API particles in the present work. The proposed development will leverage CFD-PIC and sensitivity analysis capabilities from the Department of Energy laboratories: Multiphase Flow Interface Flow Exchange and Dakota UQ software. A data-driven framework is used to obtain the reliable low order statics of the particle's residence time in the inhaler. The framework is further used to study the effect of drug particle density, carrier particle density and size, fluidizing agent density and velocity, and some numerical parameters on the particles' residence time in the inhaler.